In this photo provided by the New York Stock Exchange, a trader works on the floor during the IPO of Omnichannel Acquisition Corporation, Friday, Nov. 20, 2020. U.S. stocks are pulling a bit lower in midday trading Friday as worries about the worsening pandemic weigh on rising optimism about a coming coronavirus vaccine. (Courtney Crow/New York Stock Exchange via AP)In this photo provided by the New York Stock Exchange, traders work on the floor Friday, Nov. 20, 2020. U.S. stocks are pulling a bit lower in midday trading Friday as worries about the worsening pandemic weigh on rising optimism about a coming coronavirus vaccine. (Courtney Crow/New York Stock Exchange via AP)In this photo provided by the New York Stock Exchange, traders Thomas Lee, left, and Benjamin Tuchman work on the floor Friday, Nov. 20, 2020. U.S. stocks are pulling a bit lower in midday trading Friday as worries about the worsening pandemic weigh on rising optimism about a coming coronavirus vaccine. (Courtney Crow/New York Stock Exchange via AP)In this photo provided by the New York Stock Exchange, trader Ashley Lara works with a colleague on the floor Friday, Nov. 20, 2020. U.S. stocks are pulling a bit lower in midday trading Friday as worries about the worsening pandemic weigh on rising optimism about a coming coronavirus vaccine. (Courtney Crow/New York Stock Exchange via AP)In this photo provided by the New York Stock Exchange, traders James Riley and Ashley Lara work on the floor Friday, Nov. 20, 2020. U.S. stocks are pulling a bit lower in midday trading Friday as worries about the worsening pandemic weigh on rising optimism about a coming coronavirus vaccine. (Courtney Crow/New York Stock Exchange via AP)
New York Stock Exchange
In this photo provided by the New York Stock Exchange, a trader works on the floor during the IPO of Omnichannel Acquisition Corporation, Friday, Nov. 20, 2020. U.S. stocks are pulling a bit lower in midday trading Friday as worries about the worsening pandemic weigh on rising optimism about a coming coronavirus vaccine. (Courtney Crow/New York Stock Exchange via AP)
